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Summary 
Currently, various strategies are used to stimulate healing of bone defects and restore 
lost alveolar bone and periodontal support. The concept of tissue engineering has 
emerged as a valid approach to the current therapies for bone regeneration and is 
attracting considerable attention. Skeletal tissue engineering requires a biocompatible 
scaffold conducive to cell attachment and maintenance of cell function, in 
combination with a rich source of osteoprogenitor cells and osteoinductive growth 
factors. Selection of the most appropriate material to produce a scaffold is an 
important step towards the construction of a tissue engineered product. Copolymers of 
Poly(L-lactide)-co-(-caprolactone) [Poly(LLA-co-CL)] and Poly(L-lactide)-co-(1,5-
dioxepan-2-one) [Poly(LLA-co-DXO)], with better mechanical properties than the 
resorbable aliphatic polyester Poly(L-lactide) P[LLA], have recently been developed 
for application as scaffolds in bone regeneration. The influence of these scaffolds on 
osteogenic potential is unclear and need to be addressed. Further, little is known about 
how cells respond at a molecular level to tissue engineered scaffold materials. 
Thus the overall aims of this series of in vitro studies were to investigate 
biocompatibility and changes in gene and protein expression profiles caused by these 
scaffolds and to elicit specific expression profiles and biological pathways at the 
molecular level. The scaffolds were produced by solvent casting particulate leaching 
technique. 
The aim of Study I was to evaluate the biocompatibility of Poly(LLA-co-CL) 
and Poly(LLA-co-DXO), using the commonly used material, P(LLA) for reference. 
Scanning electron microscopy and light microscopy showed that the cells had grown 
and spread well on the test co-polymers. Indirect contact cytotoxicity tests  
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(extraction), performed according to ISO requirements, showed that the test scaffolds 
are not cytotoxic.  
The aim of Study II was to assess the growth and differentiation of human 
osteoblast-like cells (HOBs) seeded onto the two copolymer test scaffolds, Poly 
(LLA-co-CL) and Poly (LLA-co-DXO) using P(LLA) scaffolding as a control. 
Cellular response to the scaffold materials was expressed in terms of synthesis of the 
osteoblast differentiation markers collagen type 1 (Col 1), alkaline phosphatase, bone 
sialoprotein, osteocalcin (OC), osteopontin and runt related gene 2. Surface analysis 
disclosed excellent surface attachment and spread of the cells on the test scaffolds 
compared to the control. Cells grown on the test scaffolds demonstrated higher 
production of Col 1 and OC and also increased bone marker mRNA expression. 
Compared to scaffolds of P(LLA), the Poly(LLA-co-CL) and Poly(LLA-co-DXO) 
scaffolds enhanced attachment and differentiation of HOBs in vitro.  
Study II clearly showed that the different scaffold materials had influenced 
genes involved in differentiation of HOBs. Furthermore, a previous study had shown 
that Poly(LLA-co-DXO) was significantly more hydrophilic than Poly(LLA-co-CL). 
Based on these findings, selected scaffolds were loaded with HOBs for 24 hours and 
21 days for microarray screening of differential gene expression. Therefore, the aim of 
Study III was to explore and compare the gene expression profiles of HOBs derived 
from alveolar bone and to find possible biological pathways involved using cells 
involved in repair of bone defects following culture on Poly(LLA-co-DXO) or 
P(LLA). For the cells cultured on Poly(LLA-co-DXO) scaffolds, more genes were 
found to be differentially expressed (up- or down regulated) at 24 hours than at 21 
days, when compared with cells cultured on P(LLA). Most of these genes were related 
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to cell adhesion, cell cycle, cell division, cytoskeleton, anti-apoptosis, proliferation 
and bone mineralization. Three main pathways involving integrin signaling, Notch 
signaling and Ras Pathway were found. For selected candidate genes, the results were 
confirmed using quantitative real time reverse transcription polymerase chain 
reaction. 
In summary, the results demonstrated that the co-polymers tested in these 
studies are non-cytotoxic and biocompatible. Compared to scaffolds of P(LLA) and 
Poly(LLA-co-CL), the Poly(LLA-co-DXO) scaffolds enhanced attachment and 
differentiation of HOBs in vitro. Microarray analysis disclosed marked differences in 
global gene expression profiles between HOBs seeded onto Poly(LLA-co-DXO) and  
P(LLA) scaffolds, especially after 24 hours incubation. Statistical analyses at the chip 
and probe levels indicated that several genes were differentially expressed as a 
function of Poly(LLA-co-DXO) scaffolds. Detailed analysis of genes exhibiting 
differential expression revealed several molecular pathways related to cell adhesion, 
cell-cell communication and cell proliferation. Therefore, it is concluded that these 
scaffolds might be appropriate carriers for bone engineering.  
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1. Introduction 
Worldwide, the World Health Organisation has declared 2000 - 2010 as “The Decade 
of Bone and Joints”. Joint diseases account for half of all chronic conditions in people 
over 65 years of age and the incidence of fractures due to osteoporosis is increasing. 
Thus bone disease afflicts over 40 % of all women over 50 years of age and treatment 
of trauma-related skeletal deformities and skeletal disorders accounts for over 25 % of 
health expenditure of developing countries (Tsou & Chng 2002).  
Many recent advances in dentistry have been achieved by implementing new 
technologies, such as high-speed handpieces, modern restorative materials, 
improvement of prosthetic rehabilitation for replacing missing teeth, implant dentistry 
and recently tissue engineering (Baum & Mooney 2000, Tyagi & Dhindsa 2009). 
Tissue engineering is an interdisciplinary field that applies basic engineering 
principles, with the main objective of developing a biological substitute(s) capable of 
restoring, maintaining, or improving tissue function, or replacing a whole organ 
(Langer & Vacanti 1993). A basic requirement of the technique, however, is a 
fundamental interplay between cells and scaffolds and in some cases growth factors 
(Howard, et al. 2008). 
The technology of tissue engineering has the advantage of bringing together 
the power of modern biology, chemistry, and physical science with the main objective 
of helping to solve clinical problems. Of major interest is that tissue engineering can 
be applied to a number of problems that can be managed by general or specialist 
dentists. Good examples are cases involving bone or teeth fractures, craniofacial 
defects, pulp-dentin complex destruction and periodontal diseases. Thus in the field of 
dentistry, tissue engineering technology holds promise as an improved treatment 
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approach to intraosseous periodontal defects; enhancement of maxillary and 
mandibular grafting procedures and the possibility of achieving regrowth of missing 
teeth (Baum & Mooney 2000, Tyagi & Dhindsa 2009). 
In coming decades, tissue engineering technology is expected to have a 
fundamental impact on the practice of dentistry. However, before potential clinical 
applications in dentistry can be achieved, major challenges must be addressed. The 
benefits related to repair and replacement of mineralized tissues, oral wound healing 
promotion and gene transfer application may be seen during the coming years.  
In the oral cavity, management of patient problems related to structure, 
function, aesthetics and pain constitute major challenges that affect the outcome of 
treatment, a treatment being often more complex than in other parts of the body. One 
of the major challenges facing dentistry today is how to regenerate oral and 
craniofacial defects that demand a combination of basic and clinical science as well as 
the technology of tissue engineering. However, interest in how to regenerate missing 
or defective teeth, pathologically affected oral mucosa or salivary glands, bone and 
periodontium is now attracting research efforts at both national and international 
levels (Scheller, et al. 2009). 
1.1. Grafting materials 
Large bone defects caused by tumors, infectious diseases, or trauma result in major 
medical need for bone regeneration. There are four major characteristics necessary for 
the ideal bone graft material: i) osteointegration, (ii) osteoconduction, (iii) 
osteoinduction, and (iv) osteogenesis. Only autogenous bone grafts fulfil all of these 
requirements (Finkemeier 2002). This is bone transferred from one location to another 
within the same individual and is considered to be the gold standard for bone grafting 
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material. Alternatively, an allogeneic bone graft, which is bone transferred between 
genetically different members of the same species, can be used. However, allogeneic 
bone grafts confer risks of transfection and rejection. To avoid this problem, synthetic 
(alloplastic) materials have been developed as another approach in bone repair 
mechanisms (Hallman, et al. 2009, Hallman & Thor 2008). 
The limited availability of bone grafting materials, together with several other 
drawbacks restrict their application in clinical practice (Finkemeier 2002). Therefore 
alternative grafting methods have been developed. 
1.2. Bone tissue engineering concepts 
It is known that large bone defects caused for example by pathological lesions or 
trauma have a poor prognosis and reconstruction of these defects constitutes a major 
clinical challenge. A recent approach to treatment of these conditions is known as 
bone tissue engineering (BTE) (Figure 1). Although still in its infancy, the literature 
on BTE contains a considerable accumulation of knowledge about many of the key 
elements, including scaffold structure and material properties, cell sources and 
biomolecular activity (Burg, et al. 2000). 
The concept underlying BTE is to engineer autografts either by expanding 
autologous cells in vitro, guided by a scaffold, or by using an acellular scaffold in vivo
and allowing the patient’s cells to repair defective tissue, guided by a scaffold. As 
tissue regeneration proceeds, the scaffold should degrade in time; once the tissue has 
matured, the scaffold should no longer exist, allowing the newly formed tissue to 
function. This approach avoids some of the drawbacks related to grafting techniques 
(Chan & Leong 2008, Howard, et al. 2008). 
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Figure 1. Schematic representation of bone tissue engineering approach that uses 
cells and biodegradable scaffolds. Isolated bone cells from patient alveolar bone 
biopsy are expanded in vitro to achieve large number of cells, and thereafter cells are 
seeded onto scaffold materials and cultured further for several days with or without 
growth factors. Obtained tissue engineered construct will be implanted back to the 
patient to repare or heal bone defect. 
In orthopedics, BTE opens new opportunities for bone regeneration and 
substitution based on an implant composed of a biocompatible, biodegradable 
scaffold, the recipient’s own cells, and biomolecules that modulate the cells to form 
new tissue. Such an implant not only creates a local environment for pre-loaded cell 
proliferation and differentiation in the targeted tissue, but also interacts with the host’s 
own tissue and integrates into it. Ideally, the only remaining foreign component, the 
scaffold, will be degraded and excreted. In this process, the implant is eventually 
transformed into the patient’s own bone (Burg, et al. 2000). 
1. Isolation of cells from alveolar bone biopsy
2. In vitro expansion of isolated cells
3. Bone cells + Scaffold Material+ Growth factors
4. Culture the tissue engineered construct in vitro
5. Implant the tissue engineered construct into patient for bone regeneration
Bone Tissue Engineering
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1.3. Overview of bone biology 
Bone is a dynamic, highly vascularized tissue with a unique capacity to heal and 
remodel without leaving any scar (Sommerfeldt & Rubin 2001). Its main role is to 
provide structural support for the body. The skeleton also serves as a mineral 
reservoir, supports muscular contraction resulting in motion, withstands load bearing, 
and protects internal organs (Marks & Odgren 2002). In order to fulfil these functions, 
bone is therefore continuously broken down and rebuilt. 
Bone contains approximately 70% mineral, 8% water, and about 22% 
collagenous matrix, and the interactions of these constituents play major roles in 
determining the mechanical behavior of bone (Cullinane & Einhorn 2002). At the 
macroscopic level, the mature bone skeleton is arranged in two architectural forms: 
trabecular and cortical (Marks & Odgren 2002). The trabecular bone is commonly 
found in the metaphyses of long bones, covered by cortical bone, and in the vertebral 
bodies. The cortical bone on the other hand can be divided into different subgroups:  
long bones, short bones, and flat bones (Rho, et al. 1998, Salgado, et al. 2004). 
1.3.1. Bone cells 
The major cells in bone responsible for different functions include osteoblasts, 
osteocytes, osteoclasts and bone lining cells (Figure 2). Together, these cells play 
essential roles in bone formation, maintenance, and remodelling. 
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Figure 2. Schematic illustration of the different types of cells present in bone: 
Osteoblasts, Osteoclasts, Osteocytes and bone lining cells. 
Osteoblasts are mononuclear, cuboidal shaped, fully differentiated cells that 
arise from the mesenchymal stem cell lineage or precursor cells, through the process 
of osteogenesis, and are responsible for production of bone matrix and regulation of 
mineralization (Aubin 1998). Upon differentiation, these cells are known to synthesize 
and secrete type I collagen (Col 1), alkaline phosphatase (ALP), and other non-
collagenous extracellular bone matrix proteins such as osteonectin, osteocalcin (OC), 
osteopontin (OP) and bone sialoprotein (BSP). Differential gene expression of 
osteogenic cells can be defined by three principal biological processes: cellular 
proliferation, cellular maturation and focal mineralization (Aubin 1998). Col 1 is 
expressed during the initial period of proliferation and extracellular-matrix 
biosynthesis, whereas ALP is expressed during the post-proliferative period of 
extracellular-matrix maturation. The expression of osteopontin, osteocalcin and bone 
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sialoprotein occurs later, during the third period of extracellular-matrix mineralization 
(Aubin 1998). Runt related gene 2 (Runx2), which is also known as core-binding 
factor a1 (CBFA1), is an important transcriptional determinant of osteoblast 
differentiation (Franceschi 1999). Deposition of the above mentioned proteins leads to 
formation of bone matrix, which will undergo the mineralization process that 
completes bone formation (Marks & Odgren 2002). Osteocytes are mature osteoblasts 
which have been surrounded by bone matrix. These cells are involved in maintenance 
of the local bone, and the unique stellate shape with canaliculi connecting adjacent 
osteocytes makes each of them to function as a hub of cellular communication and 
nutrient delivery. Osteoclasts are large multi-nucleated cells of hematopoietic origin 
through the monocyte-macrophage lineage. They resorb bone by dissolving the 
mineral phase and enzymatically by digesting the organic macromolecules. 
Osteoclasts reside on the surface of bone and they have a ruffled bordered plasma 
membrane at their resorbing surface. Bone lining cells are flat, elongated cells that 
cover bone surfaces where neither bone formation nor resorption is taking place. 
However, little is known of their functions (Marks & Odgren 2002).  
1.3.2. Bone formation 
Newly formed bone is formed via either intramembranous ossification or 
endochondral ossification processes. In the former process, woven bone is formed 
directly from condensed mesenchymal tissue, without the intermediate formation of a 
cartilaginous framework of the future bone. It occurs primarily in the embryonic 
formation of flat bones (e.g. the skull). Endochondral ossification involves an 
intermediate, cartilaginous phase formed from mesenchymal tissue, and it is this 
cartilage framework which is then ossified to form the new bone. It occurs in the 
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embryonic formation of the long bones, in fracture repair, and in the incorporation of 
bone grafts (Marks & Odgren 2002).  
1.3.3. Cells for bone tissue engineering 
The outcome of BTE is influenced not only by the scaffolding but also by the type of 
cell selected for bone regeneration. The ideal cell source should be easily expandable 
to higher passages, non-immunogenic and have a protein expression pattern similar to 
the tissue to be regenerated. Use of autologous cells circumvents the risks of 
immunological incompatibility and transmission of infection.  
The stem cells located in the bone marrow, known as Mesenchymal Stem Cells 
(MSC), have been used in experimental BTE. Besides their differentiation potential, 
MSCs have other important properties and can be expanded extensively in vitro
(Salgado, et al. 2004). During bone formation and as MSC mature into osteoblasts, 
multiple growth factors are expressed (Wildemann, et al. 2007). 
As well as MSC, other osteogenic cells with potential application for bone 
include periosteal mesenchymal cells and osteoblasts (Coelho, et al. 2000, Oreffo & 
Triffitt 1999). Experimentally sourcing osteogenic cells from alveolar bone obtained 
during routine surgery offers two important advantages: first the cells are readily 
harvested by biopsy and second the procedure causes minimal damage at the donor 
site. 
1.4. Growth factors 
Growth factors are cytokines which function as signalling molecules for such events 
as promotion and/or prevention of cell adhesion, proliferation, migration and 
differentiation by up- or down-regulating the synthesis of several proteins, growth 
factors and receptors (Jadlowiec, et al. 2003, Lieberman, et al. 2002). Hence, these 
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molecules are essential for tissue formation and play an important role in tissue 
engineering (Hallman & Thor 2008). During bone formation, multiple growth factors 
are expressed, such as bone morphogenetic proteins (BMPs), fibroblast growth factor 
(FGF), insulin-like growth factor (IGF), platelet-derived growth factor (PDGF), 
transforming growth factor  (TGF-) and vascular epithelium growth factors 
(VEGF). Each has different roles, which may overlap (Jadlowiec, et al. 2003, 
Lieberman, et al. 2002). 
In both angiogenesis and mesenchymal cell mitogenesis, FGF are known to 
play critical roles. FGF- for example is expressed by osteoblasts and its activity has 
been identified during the early stages of fracture-healing (Canalis, et al. 1988). IGF, 
on the other hand, has been shown to play critical roles in skeletal development 
(Andrew, et al. 1993). BMPs have been studied under preclinical and clinical 
conditions (Lieberman, et al. 2002) and are expressed in the early phases of fracture 
healing (Lind & Bunger 2001). PDGF is known to be produced by osteoblasts, 
platelets and monocytes/macrophages, and it is believed to have a possible role in 
migration of MSCs to wound healing sites and in the process of bone regeneration 
(Rasubala, et al. 2003). TGF- is expressed in bone, platelets and cartilage. It has been 
shown that TGF- can stimulate HOBs to proliferate and thereby promote collagen 
production in vitro (Robey, et al. 1987). VEGF, known as a potent angiogenic factor, 
is expressed in bone fracture healing sites and is involved in regulating vascularization 
through recruitment of endothelial cells to the healing site (Furumatsu, et al. 2003, 
Uchida, et al. 2003).  
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1.5. Scaffolds for tissue engineering 
Central to BTE is the use of three-dimensional structures (3D) (Middleton & Tipton 
2000) of large surface area and high porosity with proper pore size (Holy, et al. 2000, 
Hou, et al. 2003), which function as scaffolds onto which cells with osteogenic 
properties are seeded. The scaffolds are intended to simulate bone extracellular matrix 
(ECM) by guiding cell adhesion, migration, proliferation and differentiation and tissue 
regeneration in three dimensions (Goldberg & Caplan 2004). The scaffold functions 
as a temporary guide and support during regeneration and formation of new tissue and 
requires a certain mechanical strength to maintain tissue growth and integration, but is 
not integrated. Once the new tissue is established, the scaffolding material should be 
resorbed as new tissue is generated (Hutmacher 2000, Kim & Mooney 1998). There 
should be complete degradation, producing no toxic degradation products and leaving 
no residue which could lead to chronic inflammation. Therefore, in both implanted 
and degraded forms, scaffold materials must be biocompatible and immunologically 
acceptable (Hutmacher 2000, Middleton & Tipton 2000).  
Clearly, the BTE scaffold must meet stringent requirements. Besides the 
choice of  materials that are non-mutagenic, non-antigenic, non-carcinogenic, non-
toxic, non-teratogenic, tolerate sterilization and possess high cell/tissue 
biocompatibility, the macro and micro-structural properties of the materials are of 
utmost importance (Leong, et al. 2003). 
1.5.1. Biomaterials used as bone tissue engineering scaffolds
In the past, different materials have been investigated for applications in BTE. These 
include metals which provide immediate mechanical support at the defect site, but 
exhibit poor overall integration with the surrounding tissue and may fail due to 
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infection or fatigue loading. Ceramics such as hydroxyapatite (HA) and -tricalcium 
phosphate (-TCP) have also been tested, but are brittle and have very low tensile 
strength. Thus their use is contraindicated at sites subject to significant load (Salgado, 
et al. 2004, Schieker, et al. 2006).  
Polymers of natural origin, such as collagen, fibrinogen, chitosan, starch, 
hyaluronic acid and poly(hydroxybutyrate) as well as of synthetic origin, such as 
poly(lactic acid), poly(glycolic acid), poly(-caprolactone) and copolymers (Griffith 
2002, Salgado, et al. 2004) have been investigated for BTE.  
More recently, degradable, resorbable polymers belonging to a family of 
aliphatic polyesters derived from cyclic monomers, e.g. lactide, glycolide, and -
caprolactone and their co-polymers have been proposed as potential scaffolding 
materials (Nair & Laurencin 2006, Porter, et al. 2009). In vitro, these materials 
degrade hydrolytically, and their degradation rate can be tuned by adjusting the 
hydrophobicity, molecular weight and crystallinity of the polymer chain 
(Hakkarainen, et al. 2008, Hakkarainen, et al. 2007). Polylactic Acid (PLA) is a 
biocompatible, thermoplastic, resorbable aliphatic polyester (FDA approved), which 
has been used clinically for sutures, bone fracture fixation devices and as drug release 
systems due to its low degradation rate, better processability, and mechanical 
properties. PLA is a chiral molecule, existing as l-lactide, d-lactide, and meso-lactide. 
Thus, four different types of PLA are available: poly(l-lactic acid), poly(d-lactic acid), 
poly(dl-lactic acid) and meso-poly(lactic acid). Only poly(l-lactic acid) and poly(dl-
lactic acid) have been extensively investigated as biomaterials. Biodegradable 
scaffolds of poly(L-lactide) P(LLA) have been tested as alternatives to ceramic 
scaffolding (Nair & Laurencin 2006, Porter, et al. 2009). Poly(glycolic acid) (PGA) 
has high tensile strength with very low solubility in common organic solvents and was 
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initially proposed as biodegradable suture material and bone fixation devices. 
However, due to the high degradation rate and low solubility, coupled with 
accumulation of acidic degradation products which can lead to inflammatory 
reactions, use of PGA in biomedical fields is limited (Nair & Laurencin 2006, Porter, 
et al. 2009). Poly(caprolactone) (PCL) can be obtained from an inexpensive source 
(caprolactone) and is highly soluble in organic solvents. Due to its low degradation 
rate, PCL has been investigated as a material for long-term controlled delivery of 
drugs (Nair & Laurencin 2006, Porter, et al. 2009).
There are several manufacturing methods for producing tissue engineering 
scaffolds. These methods are required to be accurate and consistent with respect to 
porosity, pore size, pore distribution and interconnectivity of the scaffolds. Over the 
years, a series of processing techniques such as solvent casting, phase separation, and 
rapid prototyping (RP) technologies, also called Solid Free Form methods such as 3-D 
Printing (3-DP), have been developed with the main objective of producing scaffolds 
with adequate properties for bone tissue engineering (Hutmacher 2000, Nair & 
Laurencin 2006, Porter, et al. 2009).
1.6. Cytotoxicity screening of biodegradable scaffolds 
The formation of a tissue structure incorporating cells and matrix, involves an in vitro
culture step. It is at this stage that cell-scaffold interactions can be evaluated, as an 
initial screening of potential scaffolding. To date, at the regulatory level, the basic 
approach is defined in the family of ISO 10993 standards (ISO Standard 109935. 2009 
& ISO Standard 109931. 2003). 
In vitro biocompatibility tests simulate the biological reactions to materials 
intended for clinical dental and medical applications (Hanks, et al. 1996, Schedle, et 
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al. 2007). Biocompatibility tests offer a less expensive means of preliminary 
evaluation of newly developed materials, reducing the probability of untoward effects 
when animal tests or clinical trials are undertaken (Hanks, et al. 1996). One of the 
most important properties of the proposed biomaterials is their potentially toxic effect 
on cells. Cytotoxicity testing is therefore the initial phase of evaluation of material 
biocompatibility (Gomes, et al. 2001, Kirkpatrick 1992, Kirkpatrick & Mittermayer 
1990). In vitro studies show a direct correlation between toxicity and cell death, 
reduced cell proliferation, altered morphology and impaired adhesion (Kirkpatrick & 
Mittermayer 1990, Pizzoferrato, et al. 1994). Cytotoxicity testing targets mainly 
substances which leach out of the biomaterials. For example, polymers often have low 
molecular weight "leachables" such as additives, stabilizer, low molecular weight 
components and initiator fragments that exhibit varying levels of physiologic activity 
and cell toxicity (Kirkpatrick 1992, Silva, et al. 2004). 
As this brief description shows, the present concept of skeletal tissue 
engineering requires a biocompatible scaffold conducive to cell attachment and 
maintenance of cell function, a rich source of osteoprogenitor cells and osteoinductive 
growth factors. Selection of the most appropriate material for scaffolding is a major 
determinant of successful outcome. 
1.7. Cell/tissue-scaffold interactions 
Cell/tissue-implant material interactions constitute the main goals in tissue 
engineering. The surface of an implant will determine its ultimate ability to integrate 
into the surrounding tissues. Surface properties such as chemistry, topography, surface 
energy and roughness often work together to control cell behavior and affect cellular 
adhesion and proliferation, and consequently tissue formation (Cassinelli, et al. 2003, 
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Lange, et al. 2002). The topographical properties are of particular interest with respect 
to osteoconduction. Chemical properties influence the ability of cells to adhere to the 
material as well as protein interactions with the latter. Although scientific 
observations on the contribution of chemical properties to tissue growth have been 
reported, the underlying mechanisms have yet to be clarified (Kieswetter, et al. 1996, 
Salgado, et al. 2004). Initially, the role of surface energy, as dictated by surface 
roughness, topography, and composition of the implant, may play a crucial  role in 
determining which proteins, lipids, salts and sugar are adsorbed onto the surface as 
well as whether or not the cells themselves adhere to the surface (Kieswetter, et al. 
1996, Salgado, et al. 2004). It has been previously shown that a ‘‘rougher’’ surface 
favors osteoblast attachment, facilitates migration of osteogenic cells to the material 
surface and the ingrowth of bone, and is therefore preferable to a smooth surface 
(Carlsson, et al. 1988, Gotfredsen, et al. 1992, Mustafa, et al. 2001, Mustafa, et al. 
2000). Pore size and interconnectivity are thus important properties, in that they can 
affect how well cells can penetrate and grow into the scaffold and at the same time 
what quantity of materials, nutrients, and wastes can be transported into and out of the 
scaffold. However, the degree of porosity will influence other properties of the 
scaffold, such as its mechanical stability: thus there must be a balance between 
porosity and the mechanical requirements of the particular tissue that is to be replaced 
(Hou, et al. 2003, Salgado, et al. 2004). Tsuruga and coworkers have suggested that 
the optimal pore size of ceramics for supporting ectopic bone formation is 300-400 
µm (Tsuruga, et al. 1997). Holmes similarly suggested that the optimal pore range is 
200-400 µm with the average human osteon size of approximately 223 µm (Holmes 
1979). Recently, Schander et al. suggested that scaffolds with pore size > 90 µm 
enhanced human periodontal ligament and alveolar osteoblast-like cell growth 
33
(Schander, et al. 2010). In contrast, Holy et al. (2000) proposed a different concept: 
that bone reconstruction will only be achieved by having a 3D temporary matrix with 
a large macroporous interconnected structure with pore size ranging from 1.2–2.0 
mm. This approach in fact has evident advantages that will facilitate cell, tissue and 
blood vessel in-growth. However, this may compromise the mechanical properties, 
precluding its application in areas requiring mechanical strength (Burg, et al. 2000, 
Holy, et al. 2000, Hou, et al. 2003). 
It is crucial that in vitro testing of the effect on cell proliferation, cell 
differentiation, and cellular behavior of candidate biomaterials for scaffolding should 
be conducted at an early stage: firstly because the scaffold materials should have the 
capacity to stimulate differentiation of osteoprogenitor cells into osteoblasts, and 
secondly, because proliferation and differentiation of osteoblasts are affected by the 
chemistry of the substratum (Zreiqat, et al. 1999).
The process of bone regeneration can be followed by monitoring markers 
associated with the different stages of osteogenesis. Because there is no single specific 
marker for osteoblasts, cellular differentiation is assessed in terms of cellular 
expression of a range of non-collagenous and collagenous proteins as well as ALP. 
Differentiating osteoblasts are known to synthesize and secrete Col 1, ALP, and other 
non-collagenous extracellular bone matrix proteins, such as osteonectin, OC, OP and 
BSP (Aubin 1998, Marks & Odgren 2002). While osteoblast activity can be assessed 
in terms of osteoblast-specific proteins, studying osteoblastic gene expression will 
provide more accurate, detailed information about cellular activity (Franceschi 1999). 
A more sensitive indicator of osteoblast acitivty, however, is the cell’s global pattern 
of gene expression.  
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1.8. Microarray gene expression profiling in tissue engineering 
The cell’s global pattern of gene expression can be monitored by microarray 
technology using large numbers of genes, spanning a significant fraction of the human 
genome, to generate a so-called genetic portrait, revealing up- or down regulated 
genes involved in the cell system under investigation. Microarray analyses allow 
monitoring of human cells even at an early stage of material design (Carinci, et al. 
2007, Carinci, et al. 2004). With the increasing availability of genetic information, the 
focus of both biological and molecular studies has begun to shift from characterization 
of individual components of a biologic system to the holistic behavior of the entire 
biological system (Iida & Nishimura 2002). Microarray analysis might be relevant to a 
better understanding of the molecular mechanisms underlying the behavior of cells in 
tissue regenerative procedure. This might facilitate the design of improved tissue 
engineering scaffolds.  
1.9. Specific background 
Biodegradable scaffolds of P(LLA) have been tested as alternatives to ceramic 
scaffolding. However, the P(LLA) polymer is hydrophobic, with a high molecular 
weight and melting point, which prolongs its degradation time (Migliaresi, et al. 
1994). The weak mechanical properties of the P(LLA) polymer scaffolds are a further 
disadvantage in structural tissue engineering applications.  
Copolymerization of lactide with monomers that have different values of 
transition temperature (Tg) and crystallinity creates opportunities for designing 
polymers with widely different properties. One of the interesting monomers is the 1,5-
dioxepan-2-one (DXO), synthesized by Albertsson and co-workers (Karlsson, et al. 
1994, Mathisen & Albertsson 1989, Mathisen, et al. 1989). The design of this 
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monomer is part of ongoing studies on the development of new monomers using ring-
opening polymerization for creating degradable biomedical materials. DXO co-
polymerized with lactide yields materials with an amorphous character and interesting 
properties for new degradable biomedical polymers (Lofgren, et al. 1994). 
To provide a variety of BTE materials with a range of properties more 
appropriately tailored to specific biomedical applications, co-polymers of L,L-lactide 
and -caprolactone (-CL) [Poly(LLA-co-CL)] or DXO [Poly(LLA-co-DXO)], have 
been produced which have different hydrophilicity and more appropriate mechanical 
properties than P(LLA) (Dånmark, et al. 2010, Kallrot, et al. 2007, Kallrot, et al. 
2008). Their mechanical properties are more suited to the demands of BTE 
scaffolding (Odelius, et al. 2005, Odelius, et al. 2008, Plikk, et al. 2006). While the 
mechanical properties have been well documented, the influence of these scaffolds on 
the behavior and osteogenic potential of the seeded cells in vitro and in vivo has yet to 
be determined. Furthermore, little is known about the response of these cells, at a 
molecular level, to tissue engineering scaffold materials. 
To date, no BTE biomaterial has resulted in an implant with optimum 
morphology, mechanical properties, biocompatibility, and biodegradability. Lack of 
an optimum material for BTE has led to increasing interest in the field of biomaterials. 
Therefore the ultimate goal of this thesis is to test the biological responses to newly 
synthesized aliphatic polyester scaffolds for BTE applications.
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2. Aims of the Study 
As the field of tissue engineering progresses, use of biodegradable polymers has 
become widespread. The manner in which these polymers are processed and the 
additives used at the time of manufacture allow the final properties of the scaffold to 
be tailored to specific applications. Aliphatic polyesters synthesized by ring-opening 
polymerization are well suited for use in bone tissue engineering. This is due to their 
biocompatibility and resorbability, and the possibility of copolymerizing monomers to 
tailor their chemical, physical and mechanical properties. The need for novel scaffold 
structures and reproducible fabrication techniques has become of paramount 
importance. Toward this end, a series of experimental in vitro studies was designed to 
investigate Poly(LLA-co-DXO), Poly(LLA-co-CL) and P(LLA), three biodegradable 
polymer scaffolds with different hydrophobicity and mechanical properties, currently 
under appraisal by our research group. Therefore, the overall aims of this thesis were 
as follows:  
General Aim 
To investigate the effect of recently designed and developed co- polymer scaffolds for 
bone tissue engineering on the initial cellular responses (Papers I-III).
Specific Aims  
• To evaluate the cytotoxicity and cytocompatibility of Poly(LLA-co-DXO) and 
Poly(LLA-co-CL) scaffolds (Paper I).
• To study the differentiation of HOBs seeded onto Poly(LLA-co-DXO) and 
Poly(LLA-co-CL),  compared with P(LLA), by examining expression and synthesis of 
osteoblast differentiation markers Col 1, ALP, BSP, OC, OP and Runx2 (Paper II).  
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• To define the most appropriate scaffold for bone tissue engineering which is 
aimed from this thesis by identifying and comparing gene expression profiles of 
HOBs following culture on  biodegradable polymer scaffolds of Poly(LLA-co-DXO) 
and P(LLA) (Paper III).
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3. Materials and Methods 
This section provides an overview of the materials and methods used in the three 
studies (Figures 3 and 4). Full details are presented in the original papers (I-III) 
included in this thesis.  
Paper I HOBs
L929s
Viability tests: MTT, LDH and 
Caspase 3/7 Activity
Cell morphology: CVS, SEM 
qRT-PCR (apoptotic markers)
Paper II HOBs
ELISA (bone markers)
qRT-PCR (bone markers)
Paper III MicroarrayHOBs
qRT-PCR (validation)
P(LLA)
Poly(LLA-co-CL)
Poly(LLA-co-DXO)
P(LLA)
Poly(LLA-co-CL)
Poly(LLA-co-DXO)
P(LLA)
Poly(LLA-co-DXO)
Cell types Scaffolds Methods 
Cell morphology: SEM 
Viability tests: MTT
Figure 3. Flow chart describing the different kinds of materials and methods used in 
the present thesis (Papers I-III). HOBs: Human osteoblast-like cells, L929s: Mouse 
fibroblast cells line, CVS: Crystal violet staining, SEM: scanning electron 
microscopy, MTT: Methylthiazol tetrazolium, LDH: Lactate dehydrogenase assay, 
qRT-PCR: Real-time quantitative reverse transcriptase- PCR and ELISA: Enzyme-
linked immunosorbent assay.  
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CytocompatibilityCytotoxicity
Indirect contact Direct contact
Use of material extracts in 
contact with cells
Use of materials in 
contact with cells
Biocompatibility tests
Figure 4. Evaluating biocompatibility by indirect and direct contact techniques. 
3.1. Scaffold preparation (Papers I- III) 
The copolymerization of L,L-lactide (LLA), 1,5-dioxepan-2-one (DXO) or -
caprolactone (CL) was performed in bulk using ethylene glycol and a low amount of 
Stannous 2-ethylhexanoate, at a ratio to monomer of approximately 1:10 000 (Figure 
5) (Stjerndahl, et al. 2008). Polymerizations were carried out at 110 ˚C for 72 h under 
nitrogen atmosphere. The resulting copolymers consisted of 75 mol % L-lactide and 
25 mol % of the corresponding comonomer, verified by 1H-nuclear magnetic 
resonance. The molecular weights were found to be ~100,000 g/mol for all polymers, 
confirmed by Size exclusion chromatography calibrated against Poly(styrene) 
standards (Odelius, et al. 2005). 
Porous 3D scaffolds of Poly(LLA-co-CL), Poly(LLA-co-DXO) and a 3D 
control of P(LLA) were prepared by a previously described solvent casting particulate 
leaching method (Dånmark, et al. 2010, Idris, et al. 2010, Idris, et al. 2010, Odelius, et 
al. 2005). Mortared sodium chloride particles (NaCl) were used as the pore-creating 
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additive and added to polymer in a ratio of 10:1 by weight, yielding a wide range of 
particle sizes with no discriminating dimensions. Total porosities of approximately 90 
vol % (Odelius, et al. 2005) were achieved for all polymer scaffolds. The chloroform 
was allowed to evaporate slowly to leave a solid composite. Scaffolds, for multi-well 
cell-culture plates, were punched out from the composites. The salt particles were 
leached from the composites by repeated soaking in deionized water and the salt-free 
scaffolds were dried under vacuum. The samples were thereafter subjected to 
irradiation under an inert nitrogen atmosphere (Odelius, et al. 2008, Plikk, et al. 2006) 
by electron beam using a 6.5 MeV pulsed electron accelerator (Microtron, 
Acceleratorteknik, The Royal Institute of Technology, Stockholm) with a radiation 
dose of 2.5 MRad. 
Figure 5. Images of P(LLA) scaffold (left), Poly(LLA-co-CL) scaffold (centre) and 
Poly(LLA-co-DXO) scaffold (right). The scaffolds have been formed as discs of 12 mm 
diameter and 1.5 mm thickness. 
3.2. Cell cultures (Papers I-III) 
In order to study the cellular reaction on each scaffold surface, two cell culture types 
were used: HOBs and the mouse fibroblast L929. HOBs were isolated from human 
mandibular bone specimens, free of any clinical or radiographic evidence of 
pathology, and were obtained from patients undergoing routine oral surgery at the 
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Department of Maxillofacial Surgery, Haukeland University Hospital and Department 
of Clinical Dentistry, Faculty of Medicine and Dentistry, University of Bergen, 
Bergen, Norway. All the donors were healthy subjects with no known systemic 
diseases. The specimens were taken from the molar region and harvested and 
maintained by a modification of the method described by Beresford et al. (1984). The 
cells were characterized using different assays (Mustafa, et al. 2001, 2000). 
An established cell line, mouse fibroblast L929 (American Type Culture 
Collection CCL 1) was cultured in Dulbecco’s modified Eagle’s medium containing 2 
mM L-glutamine (DMEM; PPA Laboratories GmbH, Pasching, Austria) 
supplemented with 10% fetal calf serum (FCS) and 1% antibiotics at 37 °C in a humid 
atmosphere containing 5% CO2. Twenty-four hours before starting each cytotoxicity 
test, cells were trypsinized and counted by a CountessTM Automated Cell Counter 
(InvitrogenTM, Carlsbad, California) prior to further use.  
In papers I-III, scaffolds measuring 12.5mm in diameter and approximately 
1.5mm in thickness were placed into 48-well culture plates and soaked with the 
culture medium [Minimum Essential Medium, alpha modification (-MEM; Gibco, 
Grand Island, NY, USA), supplemented with 1% antibiotics (penicillin/streptomycin 
solution, L-glutamine and 10% FCS. After 24 hours, HOBs that strongly expressed 
ALP and OC were seeded onto the scaffolds and allowed to incubate in 5% CO2 at 37 
°C for 1, 7, 14, and 21 days. The medium was changed every 2 days. Tissue Culture 
Polystyrene (TCPS) served as two dimensional (2D) controls.  
The study protocol for the use of HOBs was approved by The National 
Committee for Research Ethics, Western Norway (225.05, dated 07.11.05). 
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3.3. Extract preparation (Paper I) 
Scaffolds (1.25 cm2/ml) were incubated in culture medium at 37 °C with constant 
shaking (60 rpm) in order to simulate closely the effect of degradation products in a 
dynamic environment. Extract was then filtered (0.2 m pore size) to eliminate any 
solid material particles and maintained at -20°C. For the extraction tests, complete 
culture medium in TCPS served as a negative control; 20 mg/ml phenol 99+ % 
(Sigma-Aldrich, USA) in the media served as a positive control. 
3.4. Assessment of cell viability and proliferation  
3.4.1. Methylthiazol tetrazolium (MTT) assay (Papers I and II) 
Cell viability and proliferation were analyzed using MTT mitochondrial reaction. This 
is a colorimetric assay, based on the ability of live cells to reduce yellow MTT reagent 
(Sigma, St Louis, MO, USA) to a purple formazan product (Mosmann 1983). In paper 
I, L929 cells were seeded for 24 hours with 24 hour and 7 day extracts. Negative and 
positive controls were also included.  
In paper II, HOBs and scaffolds were washed with PBS (phosphate buffered 
saline) and transferred into new well plates after 1 and 7 days. MTT reagents were 
added to each sample and incubated in the dark for 4 hours at 37 °C, under a CO2
(5%) atmosphere. MTT was aspirated and the formazan product was solubilized in 0.5 
ml DMSO containing 6.25% (v/v) 0.1 M NaOH and the end product was quantified 
by microplate spectrophotometry (BMG LABTECH, GmbH, Germany) at a 
wavelength of 570 nm and expressed as optical density units (OD) after blank 
subtraction. 
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3.4. 2. Lactate dehydrogenase assay (LDH) (Paper I)
Cell viability and cytotoxicity were also evaluated by measuring the viability of L929 
cells on the newly developed scaffolds via total cytoplasmic lactate dehydrogenase, 
using the commercially available kit TOX-7 (In vitro Toxicology Assay Kit, lactic 
dehydrogenase based, Sigma-Aldrich, USA) in accordance with the manufacturer’s 
instructions (Weyermann, et al. 2005). OD at 450 nm was recorded and taken as a 
measure for the quantity of cells. 
3.5. Cell morphology 
3.5.1. Crystal violet staining (CVS) (Paper I) 
HOBs were cultivated for 24 hours and incubated with extract from the various 
scaffolds or with control culture medium for another 24 hours. Briefly, cultured cells 
were fixed in 10% formalin buffer at room temperature for another 2 min and stained 
with crystal violet for 2 min. The attached cells were washed gently with distilled 
water and allowed to dry overnight. The samples were photographed under light 
microscopy with an inverted optical microscope (NIKON ECLIPSE TS100, 
Invitrogen, Japan). 
3.5.2. Scanning electron microscopy (SEM) (Papers I and II) 
The surface topography of the scaffolds and cellular morphology were documented by 
SEM (Jeol JSM-7400F, Tokyo, Japan). The scaffolds were seeded with HOBs, and 
the samples were fixed in glutaraldehyde, dehydrated, critical point dried and sputter-
coated with a layer of gold-platinum for observation by SEM. 
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3.5.3. Scaffold histology (Paper III)
Poly(LLA-co-DXO) scaffold seeded with HOBs were prepared for histological 
analysis. The presence of cells within the scaffolds was demonstrated by sectioning 
the construct and staining the cell nuclei with propidium iodide (PI). Sections (8 µm) 
were cut by using a microtome (Cryostat, Leica CM 30505, Leica Microsystems 
Nussloch Gmblt, Germany) and analysed by fluorescence microscopy for PI- stained 
nuclei to identify the location of cells within the scaffolds. 
3.6. Determination of cell death (Paper I) 
3.6.1. Caspase 3/7 activity assay 
Apoptosis was measured via active caspases 3/7 in whole living, intact cells using 
Magic Red Caspases 3/7 Detection kit (ImmunoChemistry Technologies, 
Bloomington, USA), following the manufacturer’s instructions. Cells on the scaffolds 
were incubated with staurosporine to induce apoptosis and used as positive control. 
The intensity of fluorescence was measured with a fluorescence plate reader at 540-
590 nm excitation and >610 nm emission.  
3.6.2. Bcl-2 and Bax gene expression levels  
The effects of test scaffolds on the gene expression levels of Bcl-2 (anti-apoptotic) 
and Bax (pro-apoptotic) in HOBs were studied using real time qRT-PCR. 
3.7. Enzyme-linked immunosorbent assay (ELISA) (Paper II) 
Col 1 and OC, expressed into the medium by the HOBs that had grown on the 
scaffolds for 7, 14 and 21 days, were measured by a human-specific ELISA using the 
commercially available kits Metra™ CICP Enzyme Immunoassay Kit 
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(QUIDEL/METRA, San Diego, USA) and Immunoassay Kit Human Osteocalcin 
(BioSource™ Europe S.A., Nivelles-Belgium), in accordance with the manufacturer’s 
instructions.  
3.8. RNA isolation (Papers I-III) 
In papers I and II, the scaffold and the cells were washed in PBS and total RNA was 
isolated at different culture times, using combined TRIzol® reagent (Gibco BRL, 
Carlsbad, CA, USA) and E.Z.N.A.TM Tissue RNA kit (Omega Bio-Tek, Doraville, 
USA) protocols, following the manufacturer’s instructions. The quantity and quality 
of the extracted RNA were checked by spectrophotometry and 300 ng of the total 
RNA was reverse transcribed using High-Capacity cDNA Archive Kit system for 
cDNA synthesis.  
In paper III, total RNA was extracted (from six independent biological 
replicas) using lysis buffer with ß- Mercaptoethanol and E.Z.N.A.TM Tissue RNA kit 
protocols, following the manufacturer’s instructions. Only RNA samples with an 
A260/A280 ratio of 1.9–2.1 were selected for further analyses after further quality and 
quantity control by The Norwegian Microarray Consortium facilities (NMC).  
3.9. Real-time quantitative reverse transcriptase- PCR (qRT-PCR) (Papers I-III) 
Quantitative real-time PCR assays were performed using ABI StepOnePlusTM Real-
Time PCR System (Applied Biosystems, Foster City, USA). PCR amplification of the 
selected markers was done in triplicate with 10 l reaction volume each. PCR 
reactions contained 0.5 l of TaqMan probes [for apoptotic markers (Paper I), bone 
markers (Paper II), probes for genes selected for validation of microarray findings 
(Paper III)], 3.5 l of nuclease free water, 5 l of TaqMan universal fast PCR master 
mix (Applied Biosystems) and 1 l cDNA. Thermocycling conditions were 95 ºC for 
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20 s, followed by 40 cycles at 95 ºC for 1 s and 60ºC for 20 s. Gene expression levels 
were calculated according to the comparative 2-Ct method (Livak & Schmittgen 
2001) and normalized relative to GAPDH as the reference housekeeping gene, in each 
of the RNA samples (CT = CT, target - CT,GAPDH).  
3.10. Gene expression profiling and data preprocessing (Paper III) 
3.10.1. Experimental design 
Microarray technology enables simultaneous detection of expression of thousands of 
genes in the same sample. For Study III, the microarray platform Illumina was used. 
Illumina is a one-channel system which uses HumanWG-6 v3.0 Expression 
BeadChips. The one channel nature of the platform yields the simple design of one 
sample to be hybridized to one array on a microarray slide. The particular chip used in 
the present study has 6 arrays on each slide. 
3.10.2. RNA quality control 
To evaluate RNA quality, the Agilent 2100 Bioanalyzer chips (Agilent Technologies, 
Wilmington, DE, US) and the NanoDrop ND- 1000 were used. RIN values of 7.5 or 
more were chosen for microarray experiments (Figure 6). 
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Figure 6. Examples of electropherograms of RNA of different quality and RNA 
Integrity Numbers (RIN). The RIN value ranges from 2 (degraded RNA) to 10 (perfect 
RNA). 
3.10.3. cDNA synthesis, labelling and microarray hybridization 
Microarray experiments were performed using the Illumina iScan Reader, which is 
based on fluorescence detection of biotin labelled cRNA. Of each sample, 250 ng of 
the total RNA was reversely transcribed, amplified and Biotin-16-UTP –labelled, 
using the Illumina TotalPrep RNA Amplification Kit (Applied Biosystems/Ambion, 
USA). Then 1500 ng of the biotin labelled cRNA was hybridized at 58˚C for 16 hours 
and 50 minutes to the HumanWG-6 v3.0 Expression BeadChip (targeting >48 000 
probes derived from human genes in the NCBI RefSeq database and UniGene 
database), according to the manufacturer’s instructions (Figure 7).  
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Figure 7. Biotin labelling of total RNA using the Illumina TotalPrep Amplification Kit 
from Ambion. Total RNA from each sample was reversely transcribed, amplified and 
Biotin-16-UTP –labelled. Biotin labelled cRNA was hybridized to the HumanWG-6 
v3.0 Expression BeadChip. The data from the scanning of arrays on Illumina iScan 
Reader was investigated in GenomeStudio and J-Express 2009. 
Data obtained from scanning of the arrays on the Illumina iScan Reader were 
therafter subjected to further analysis using GenomeStudio and J-Express 2009 
software programs for quality and control measures.  
3.10.4. Quality control and preprocessing of the data 
All images from the scans were inspected visually. The raw data from the scans were 
controlled in the GenomeStudio software where internal controls on the array were 
checked, and control plots were constructed to search for outliers. SampleProbeProfile 
was loaded into J-Express software (Dysvik & Jonassen 2001) and further quality 
control of the data was performed using Log2-transposed data for quality control.
For detection of outliers, i.e. samples that behave differently from other 
samples regardless of the biology, both hierarchical clustering (Figure 8) and 
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correspondence analysis (Figure 9) were used. No outliers were found: samples from 
the same donor were clustered. This indicated that the quality of the data set is 
acceptable, and further analysis could proceed with all samples included in the data 
sets. 
8A
8B
24 hours 24 hours
21 days 21 days
Figure 8. Global hierarchical clustering of samples after 24 hours (8A) and 21 days 
(8B), un-normalized data to the left and quantile normalized data to the right. We 
generally see samples from the same donor clustering together. No outliers are 
observed.  
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9A
9B
24 hours 24 hours
21 days 21 days
Figure 9. Correspondence analysis plot after 24 hours (9A) and 21 days (8B), un-
normalized data to the left and quantile normalized data to the right. Samples from 
the same donor are clustered together. No outliers are observed.  
3.11. Statistical analysis (Papers I-III) 
In papers I-III, statistical analysis was performed using SigmaStat version 3.1 package 
software and One Way Analysis of Variance (ANOVA) with All Pairwise Multiple 
Comparison tests, followed by Tukey Test. Differences between the means were 
considered statistically significant when P<0.05.For microarray data (paper III), gene 
expression data were analyzed using J-Express 2009. Rank Product (RP) test was used 
to determine differences in gene expression levels of HOBs grown on two types of 
scaffolds (Breitling, et al. 2004). Changes in gene expression profiles between pairs of 
groups were identified using RP tests at an estimated false discovery rate (FDR) of 
less than 10 %. The differentially expressed genes were mapped to gene ontology 
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(GO) directed acrylic graph (DAG) in the J-Express 2009 and compared with the total 
number of probes (>48 000) to determine over-representation of the GO terms 
(Draghici, et al. 2003). A similar analysis was performed against a reference list of 
genes (NCBI: H. sapiens gene) in the protein analysis through evolutionary 
relationships (PANTHER) classification system (http://www.pantherdb.org/) using the 
Gene Symbol for each gene to identify over-represented key pathways. Bonferroni 
correction for multiple testing was applied. 
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4. Results and Discussion 
4.1. Biocompatibility of polyester co-polymer scaffolds
In paper I, extracts following soaking of scaffolds with medium, were used to assay 
cytotoxicity, i.e. by applying indirect contact methods. The MTT results revealed that 
the extracts from P(LLA), Poly(LLA-co-CL) and Poly(LLA-co-DXO) scaffolds 
soaked for 24 hours and 7 days did not affect the viability or  proliferation activity of 
the L929 cell line. The proliferation corresponded well with that in the control 
medium and no inter-scaffold differences were observed (P >0.05). The direct contact 
method, using LDH assay for the analysis, showed that the cells were able to grow 
and proliferate quite well. A noncytotoxic effect was noted for all three scaffolds. 
Comparison with the negative control disclosed no statistically significant differences 
after 24 hours. Cell proliferation in all the 3D scaffolds showed a continual increase 
from 24 hours to 7 days. The cell proliferation values for the Poly(LLA-co-DXO) 
scaffolds were significantly higher than those for the P(LLA) scaffold and TCPS (p 
<0.05). This might be attributable to greater hydrophilicity of the Poly(LLA-co-
DXO), as previously demonstrated for Poly(LLA-co-DXO) copolymer films 
compared to P(LLA) polymers (Dånmark, et al. 2010). These results are consistent 
with those of previous studies, in which PLA/glass foams, P(LLA) films with apatite 
or apatite/collagen composite coating and PLLA films modified with poly(ethylene 
imine), respectively, markedly improved the adhesion, viability, proliferation and 
function of HOBs compared with PLA/glass foams and P(LLA) films, respectively 
(Chen, et al. 2008, Liu, et al. 2009, Navarro, et al. 2004). 
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HOBs were cultivated in extracts from P(LLA), Poly(LLA-co-CL) and 
Poly(LLA-co-DXO) scaffolds, stained and observed by inverted phase contrast 
microscopy. Cell viability staining indicated that HOBs showed good viability after 
incubation for 24 hours. No obvious differences in cell morphology were observed 
between cells grown on TCPS with scaffold extracts, compared to TCPS with -
MEM. The results confirmed the in vitro biocompatibility of both Poly(LLA-co-CL) 
and Poly(LLA-co-DXO) scaffolds with the two cell types, promoting cell 
proliferation without a cytotoxic effect. SEM is a valuable technique for visualising 
cell morphology and distribution along the scaffold surface and its inner pores. The 
SEM micrographs showed good spread of the cells on the test scaffolds. Moreover, 
the cells adhered to the scaffold surface, with some of the cells attaching to pore rims.  
Apoptosis, or programmed cell death, is a physiological process of cell death 
and is thought to be involved in every homeostatic and pathological process in the 
body (Gastman 2001). In the present study, apoptotic activity within HOBs on the 
three scaffolds was investigated using a fluorogenic substrate for caspases 3/7 and 
real time RT-PCR. The results for cell death showed that at 24 hours, the enzymatic 
activity of caspases 3 and 7 on the scaffolds was similar to that on the negative 
control (P >0.05). mRNA expression of Bcl-2 and Bax was assessed by qRT-PCR 24 
hours and 7 days post-seeding of HOBs onto P(LLA), Poly(LLA-co-CL) and 
Poly(LLA-co-DXO) scaffolds. After 24 hours, no statistically significant differences 
were found in HOBs seeded onto the test scaffolds in comparison with the control. 
However, after 7 days, significant changes were observed: an increase in Bcl-2 and a 
decrease in Bax expression (P <0.05). At this time-point, better cell viability and 
fewer cell deaths were noted for the Poly(LLA-co-DXO) scaffold.  
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Bcl-2 and Bax belong to a gene family involved in the regulation of cellular 
apoptosis. In a viable cell, proapoptotic members such as Bax have an antagonist 
antiapoptotic member such as Bcl-2 (Adams & Cory 1998). Downstream from Bcl 
proteins in the apoptotic cascade are the caspases, a family of intracellular cysteine 
aspartic specific proteases which play a pivotal role in apoptosis. Moreover, the 
increase in caspase-3 activity is synchronized with increased Bax and decreased Bcl-2 
expression. Bcl-2 inhibits apoptosis and contributes to cell survival and resistance of 
cells to damage: cell survival is enhanced under conditions of relatively high 
expression of Bcl2 and low expression of Bax (Chinnaiyan & Dixit 1996, 
Chinnaiyan, et al. 1996, Gillardon, et al. 1995). Thus the present results confirmed 
that apoptopic activity, measured in terms of Bc12 and Bax expression and caspase 3 
and 7 activity, was not increased in cells seeded onto the test scaffolds. The 
enhancement of proliferation of HOBs on the test scaffolds compared to PLLA, as 
shown by MTT, LDH and SEM, are in accordance with the data reported by Dånmark 
et al. (2010) and with the result presented in paper II (Idris, et al. 2010). The observed 
caspase activity is supported by the qRT-PCR results, confirming that the newly 
developed scaffolds do not induce death of HOBs.  
4.2. Polyester co-polymer scaffolds enhance expression of bone markers  
In Paper II, scaffolds without HOBs were examined by SEM, to document the surface 
texture of the three types of scaffolds used. SEM micrographs showed that the 
scaffolds contain pores ranging from a few micrometers up to several hundred 
micrometers. A preceding study on scaffolds fabricated using the same wide range of 
salt particles showed that most pores were in the range of 20-150 µm (Odelius, et al. 
2005). To assess spread and morphology of the HOBs grown on the scaffolds, the 
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surface of each scaffold was examined by SEM. On day 1 of culture, there was a 
pronounced difference between the test and control scaffolds: more cells had attached 
to the test scaffolds, the cells had spread well and the pseudopodia were elongated. 
Furthermore, on both test scaffolds the cells had started to form sheets, indicating 
good attachment. After 1 and 7 days of culture, the viability and proliferation of 
HOBs grown on the Poly (LLA-co-CL) and the Poly (LLA-co-DXO) scaffolds were 
significantly higher (P < 0.05) than on the P(LLA) scaffold. On day 14, a thick layer 
of cells and ECM had formed on both test scaffolds. On the control scaffold, fewer 
and more widely separated cells were observed. For all three scaffolds, MTT activity 
increased with culture time, indicating adequate cell proliferation.  
SEM and MTT analysis disclosed that the HOBs had responded well to the 
Poly(LLA-co-CL) and Poly(LLA-co-DXO) scaffolds. In contrast, the surface of the 
P(LLA) scaffold showed poor cellular attachment and proliferation. The Poly(LLA-
co-CL) and Poly(LLA-co-DXO) scaffolds also showed higher MTT activity than the 
PLLA scaffold. The physical and chemical properties of biomaterial surfaces, such as 
topography, chemical composition, and hydrophilicity, could affect cell-biomaterial 
interactions (Chen, et al. 2008). Thus, the present results suggest that the test scaffolds 
had a positive influence on cellular viability and proliferation. A previous study on 
different triblock copolymers of DXO and LLA, where DXO was the middle block, 
showed that the hydrophilicity increased with the amount of DXO and that both 
keratinocytes and fibroblasts adhered best to the most hydrophilic material (Mattioli-
Belmonte, et al. 2005). Another recent study reported the more hydrophilic nature of 
the Poly (LLA-co-DXO) scaffold with a contact angle of 75° ±5°, compared to  the 
Poly(LLA-co-CL) scaffold with a contact angle of 85° ±3° and the P(LLA) scaffold 
with a contact angle of 86° ±2° (Dånmark, et al. 2010). Furthermore, Chen et al. 
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(Chen, et al. 2008) reported high efficiency of attachment, proliferation, and viability 
of HOBs on a more hydrophilic apatite/collagen composite coated P(LLA) film 
compared with P(LLA) control film.  
After culturing of HOBs on the three scaffolds, concentrations of Col 1 and 
OC in the culture media were quantified by ELISA. Col 1 production was 
significantly higher (P< 0.05) on the Poly (LLA-co-DXO) test scaffold than on the 
control P(LLA) throughout the culture period, whereas OC production increased over 
time in the test scaffolds and was significantly higher (p < 0.05) on the Poly (LLA-co-
DXO) scaffold than on the control scaffold throughout. 
The qRT-PCR results showed significantly higher (p < 0.05)  mRNA levels of 
the bone markers ALP, Col 1, BSP, OC, OP, and Runx2 in HOBs grown on the test 
scaffolds [Poly(LLA-co-CL) and the Poly(LLA-co-DXO)] than on the control 
scaffold P(LLA). Other studies have indicated that the hydrophobic/hydrophilic nature 
of biomaterials could affect differentiation of mesenchymal stem cells (Curran, et al. 
2006). 
Runx2 is involved in direct regulation of Col 1, BSP and OC expressions 
(Bjerre, et al. 2008). In the present study, Runx2 expression by HOBs grown on the 
Poly (LLA-co-CL) and the Poly(LLA-co-DXO) scaffolds on day 14 increased more 
than 3.0-fold, compared with 1.1-fold for the control scaffolds. This suggests that the 
test scaffolds stimulated bone cells to constant expression of Runx2, which promotes 
osteoblast maturation. The reduced expression of Runx2 on day 21 suggests the 
presence of a negative feedback mechanism that controls Runx2 expression after 
maximum expression on day 14. These results are in accordance with those of 
previous studies of expression of Runx2/Cbfa1 by human mesenchymal stem cell 
(hMSC) and HOB cell lines grown on different types of scaffolds of silicate-
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substituted tricalcium phosphate (Si-TCP) (Bjerre, et al. 2008), coral (Foo, et al. 2008) 
and coralline hydroxyapatite (Mygind, et al. 2007).
ALP is a known marker for osteoblastic phenotype characterization of HOBs 
cultured in vitro (Aubin 1998) and is one of the most commonly used markers for 
osteogenic differentiation (Kasten, et al. 2008). In this study, ALP expression by the 
cells grown on the Poly(LLA-co-CL) and Poly(LLA-co-DXO) scaffolds peaked on 
day 7 and decreased on days 14 and 21 compared to the control scaffold. Similarly, 
Bjerre et al. reported an increase in ALP expression by hMSCs seeded for up to 21 
days on Si-TCP scaffolds on day 7 but a decrease on days 14 and 21 (Bjerre et al. 
2008). In contrast, Malicev et al. investigated the expression of several bone markers 
by alveolar bone cells seeded onto constructs made of a fibrinogen solution (fibrin 
glue) and high porosity hydroxyapatite granules for up to 21 days and reported an 
increase in ALP expression on day 14 (Malicev, et al. 2008). Such discrepancies in 
results may be attributable to differences in culture method and scaffold type. In the 
present studies, the cells were statically cultured and the pore size range was similar 
for test and control scaffolds. The results confirm that the test scaffolds have the 
properties required to promote osteogenic differentiation. 
Col 1 is the most abundant protein of ECM, comprising about 90% of the 
organic phase of bone. It is expressed during the initial period of proliferation and 
extracellular-matrix biosynthesis (Aubin 1998). In paper II, expression of Col 1 by 
HOBs grown on the Poly(LLA-co-CL) and Poly(LLA-co-DXO) scaffolds, was 
measured by qRT-PCR, and was found to be greater than that of HOBs from the 
control P(LLA) scaffolds. In a study of two types of coralline hydroxyapatite scaffolds 
which differed in porosity and pore size, Mygind et al. reported an increase in Col 1
by hMSCs retrieved from the scaffolds from day 7 to day 21 (Mygind, et al. 2007). 
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 The porosity of the scaffold with a mean pore size of 200 µm was 75%, while 
that of the scaffold with a mean pore size of 500 µm was 88%. The only significant 
difference in Col 1 expression between the two types of scaffolds occurred on day 21, 
and the highest expression was found for the scaffold with a mean pore size of 500 
µm. 
Analysis of the present results revealed no pronounced differences between the 
test and the control scaffolds with respect to the porous structure. This suggests that 
the material properties may be responsible for the differences in gene expression. 
Moreover, ELISA results confirmed the qRT-PCR finding. Thus at 7 days, HOBs 
seeded onto Poly(LLA-co-CL) and Poly(LLA-co-DXO) scaffolds exhibit greater 
synthesis of Col 1 protein than those seeded onto P(LLA) scaffolds. 
BSP is an indicator of cellular maturation (Mygind, et al. 2007). In paper II, 
expression of BSP by cells grown on the Poly(LLA-co-CL) and the Poly(LLA-co-
DXO) scaffolds was relatively greater than the control on day 7 and day 14 and 
greatest on day 21. The genetic expression of this marker revealed an increase in the 
level of cellular maturation. In a study of statically cultivated coralline hydroxyapatite 
scaffolds with a mean pore size of 200 µm, Mygind et al. reported a decrease in BSP
expression by MSCs on day 14 and increases on days 7 and 21 (Mygind, et al. 2007). 
However, Ma et al. demonstrated that MC3T3-E1 osteoblasts, cultured in vitro on 
highly porous P(LLA)/hydroxyapatite composite scaffolds, showed increased BSP
expression on day 14 compared with P(LLA) scaffold (Ma, et al. 2001). 
Hydroxyapatite has osteoconductive properties and closely resembles the mineral 
phase of bone: its incorporation into P(LLA) scaffolds clearly enhanced  expression of 
BSP. The inconsistencies in BSP expression reported in the literature might be 
attributable to differences in scaffold materials, cell types, porosities, and pore sizes. 
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OC is the most specific protein marker of mature osteoblasts and can be detected 
during the earlier phases of proliferation and matrix maturation (Aubin 1998). In the 
present study, qRT-PCR results disclosed higher levels of expression of OC mRNA 
by the cells grown on the Poly(LLA-co-CL) and Poly(LLA-co-DXO) scaffolds than 
on the control scaffolds throughout the culture period, with greatest expression on day 
21. Malicev et al. reported an increase in OC expression by alveolar bone cells 
cultured in tissue-engineered hydroxyapatite granule constructs on day 7, followed by 
a decrease on days 14 and 21 (Malicev, et al. 2008). In contrast, a study of osteoblasts 
seeded onto coral scaffolds in static culture showed an increase in OC expression at 7 
and 18 days (Foo, et al. 2008). In the present study, ELISA disclosed greater OC 
expression by HOBs grown on the Poly(LLA-co-CL) and Poly(LLA-co-DXO) 
scaffolds than on the P(LLA) scaffold, progressively increasing towards day 21. This 
suggests that the test scaffolds might induce earlier cell maturation. The HOBs grown 
on the test scaffolds showed the same tendency with respect to osteogenic mRNA and 
the translated proteins for Col 1 and OC at a given time point. This indicates a 
correlation between levels of mRNA and protein expression for the same scaffolds. 
OP is one of the predominant noncollagenous proteins in bone tissue (Aubin 
1998) and is produced by osteoblasts (Foo, et al. 2008). Expression of OP by the 
osteoblasts seeded onto the Poly(LLA-co-CL) and Poly(LLA-co-DXO) scaffolds was 
also relatively higher than  from the control P(LLA) scaffolds. The consistent 
osteoblastic expression of OP indicates that the Poly(LLA-co-CL) and Poly(LLA-co-
DXO) scaffolds might promote mineralization by expressing organic protein, which 
aids in bone regeneration. These results are consistent with those of previous studies 
of expression of OP by HOB cell lines and hMSC grown on different types of coral 
scaffolds (Foo, et al. 2008) and coralline hydroxyapatite (Mygind, et al. 2007). 
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4.3. Gene expression profile of cells attached to polyester co-polymer scaffolds 
The results of study II clearly showed that the test scaffolds had influenced genes 
involved in differentiation of HOBs. On the basis of these findings, microarray 
analysis was applied in Paper III, in order to better understand the differential impact 
of the Poly(LLA-co-DXO) and P(LLA) scaffolds on the osteogenic activity of seeded 
HOBs and to determine whether these scaffolds alter the gene expression profile of 
the HOBs. For this, we used the Illumina microarray platform containing more than 
48,000 probes derived from human genes in the National Center for Biotechnology 
Information (NCBI) representing the whole human genome. 
In paper III, we identified several genes whose expression profile was up- or 
down-regulated at 24 hours. In contrast, very few genes were differentially expressed 
at 21 days. This finding may be related to the good adaptation of the HOBs to the 
Poly(LLA-co-DXO) and P(LLA) scaffolds following a longer incubation period. 
Among the genes that were found as differentially expressed at 24 hours, many were 
related to cell adhesion (including i.a. integrin alpha 3 [ITGA3], immune response 
(interleukin 8 [IL8]), skeletal system development (insulin-like growth factor 2 
[IGF2]), apoptosis regulation (heme oxygenase 1 [HMOX1}, Growth arrest and 
DNA-damage-inducible protein GADD45 alpha [GADD45A]), proliferation (Notch 
homolog 1, translocation-associated [NOTCH1], jagged 1 [JAG1]) and skeletal 
system development (ALP). Gene related to bone mineralization (ALP) was also 
differentially expressed at day 21, in addition to genes involved in ossification 
(stanniocalcin 1 [STC1], matrix Gla protein [MGP]) and apoptosis 
(serum/glucocorticoid regulated kinase 1 [SGK]). 
PANTHER analyses provided valuable mechanistic information about three 
key biological pathways involving integrin, Notch and Ras. Integrins constitute a 
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widely expressed family of cell surface receptors that are involved in cell-extracellular 
matrix (ECM), cell-cell adhesion, cell–cell interaction and in stimulation of specific 
signal transduction pathways (Danen & Sonnenberg 2003, Giancotti & Ruoslahti 
1999, Shattil, et al. 2010). Moreover, integrins are important regulators of cellular and 
host responses to implanted devices, biological integration of biomaterials and tissue-
engineered constructs (Anderson 2001, Anderson 2006, Lutolf & Hubbell 2005). In 
the present study, HOBs cultured onto Poly(LLA-co-DXO) scaffold expressed higher 
levels of ITGA3, ITGA5 and ITGB4 genes than HOBs cultured onto P(LLA) scaffold 
construct, at 24 hours. Ras is a key regulator of cell growth, differentiation and 
survival (Vojtek & Der 1998). In the present study HOBs cultured onto Poly(LLA-co-
DXO) scaffold which has high hydrophilicity expressed higher levels of genes related 
to Ras pathway than HOBs cultured onto P(LLA) scaffolds. Our findings are also in 
agreement with other studies comparing behavior of osteoblastic cells on hydrophilic 
and hydrophobic surfaces (Chang, et al. 2005). Taken together, we suggest that Ras
pathway is an essential target that warrants careful consideration when surface 
modifications of hydrophobic biomaterials are going to be tested in order to induce 
adequate cell responses in the bone tissue. Notch is a transmembrane receptor that 
mediates local cell-cell communication and coordinates a signaling cascade present in 
all animal species studied to date. The major biological role of Notch signaling is to 
control the developmental fates of cells, and cells become distinguished from one 
another according to whether they predominantly send or receive Notch signals (Lai 
2004, Mumm & Kopan 2000). Calvi et al (2003) reported an increase in the trabecular 
bone mass and overexpression of the Notch ligand, JAG1 in the osteoblasts. Our 
results showed up-regulation of JAG1 in HOBs grown into Poly(LLA-co-DXO) 
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scaffold at 24 hours and the PANTHER search also revealed a Notch signaling 
pathway. 
 In study III, many genes which regulate osteoblastic differentiation and bone 
formation - e.g. insulin-like growth factor 2 (IGF2) and platelet derived growth factor 
(PDGFA) - were significantly up-regulated in HOBs seeded onto Poly(LLA-co-DXO) 
scaffolds for 24 hours. The microarray data revealed the presence of osteoblast marker 
genes (COL 1, OC, OP, osteonectin, and Runx2) in both test and control scaffolds. 
These findings are consistent with those of previous studies carried out by our group 
on Poly(LLA-co-DXO) and P(LLA) scaffolds, and demonstrated that mRNA 
expression and protein levels for the above genes from different types of bone cells 
increased with Poly(LLA-co-DXO) scaffold compared to the P(LLA) scaffold 
(Dånmark, et al. 2010, Idris, et al. 2010, Schander, et al. 2010, Xue, et al. 2010). 
The genetic profiles described in different studies may vary depending on the 
time point selected in the experimental design. In Paper III, the time points of 24 
hours and 21 days of stimulation were selected in order to gain information about 
cellular activity during the early and late stages of cell stimulation. The genes 
elaborated on represent only a limited number of those found to be differentially 
expressed. Microarray data for some of the genes with known functions were further 
validated by qRT-PCR. In order to gain  a global comprehension of the molecular 
events related to Poly(LLA-co-DXO) scaffold/cell interaction, however, further 
studies are necessary using a variety of scaffolding surfaces, osteoblast-like cell lines 
and different time-points. 
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5. Concluding Remarks 
Tissue engineering concepts combine multidisciplinary knowledge with cutting-edge 
technologies, in order to achieve regeneration of damaged or lost tissue. Biomaterials 
suitable for tissue engineering must meet stringent requirements with respect to 
biocompatibility, biodegradability and biomechanical properties. 
The present studies concern a new generation of biodegradable biomaterials, 
Poly(LLA-co-DXO), Poly(LLA-co-CL) and copolymers of P(LLA), with great 
potential for tissue engineering, particularly in orthopedic applications. In particular, 
Poly(LLA-co-DXO) has emerged as a good candidate for bone tissue engineering 
applications, exhibiting many desirable properties such as biocompatibility, 
biodegradability, tunable mechanical stability, flexible surface properties, and wide 
availability. The studies on which this thesis is based showed that the copolymer 
scaffolds are cytocompatible with HOBs, and do not impair cell adhesion and 
proliferation. The scaffolds are not cytotoxic and cells adhered well to scaffold 
surfaces during the first 24 h. Cell viability, cytotoxicity and apoptosis assays 
reflected good cell growth and proliferation. In vitro, the test scaffolds met 
cytocompatibility requirements and therefore warrant further investigation as 
promising constructs for application in bone tissue engineering.  
The results of these studies also support the hypothesis that co-polymer 
scaffolds might be appropriate cell carriers, superior to P(LLA) and suitable for 
osseous tissue engineering. Initially, more cells attached to the test scaffolds than to 
control scaffolds of P(LLA), and after 14 days more extensive ECM formation and 
cell growth were observed. Enhanced osteoblast proliferation and differentiation were 
demonstrated by increased mRNA expression of the ALP, COL 1, BSP, OC, OP, and 
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Runx2 genes. Compared to control scaffolds, the test materials supported early 
osteoblast maturation, increasing the secretion of bone matrix, which aids in bone 
regeneration. In vivo studies are now warranted to compare the performance of the 
HOB/scaffold constructs in a clinical bone tissue engineering context. 
The results demonstrated a profound difference in the global gene expression 
profiles of HOBs grown on Poly(LLA-co-DXO) and P(LLA) scaffolds, especially 
after initial incubation of 24 hours. Statistical analyses at the chip and probe levels 
indicated that several genes were differentially expressed as a function of Poly(LLA-
co-DXO) scaffolds. More detailed examination of the differentially expressed genes 
revealed several interesting molecular pathways related to cell adhesion, cell-cell 
communication and cell proliferation. The study presented a model for gathering data 
about cell/biomaterial interactions at the molecular level. The various biological 
pathways found to be associated with Poly(LLA-co-DXO) scaffold interactions might 
be explored individually in greater detail. In future, proteomic studies might be 
applied to reveal the relationship between transcript and protein levels. Further studies 
are warranted to examine the cellular response, in terms of specific HOB markers or 
signalling pathways, stimulated by interaction with scaffolding.  
6. Future Research Directions and Challenges 
The results presented in this thesis not only indicate potential directions for future 
research, but also raise several important questions which need to be addressed if 
Poly(LLA-co-CL) and Poly(LLA-co-DXO) scaffolds are to be tested or applied for 
orthopedics and in particular, in the broader field of tissue engineering. Among the 
most challenging issues to be addressed are the mechanical properties, large-scale 
production and controllable degradation. 
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